178 related articles for article (PubMed ID: 34445757)
21. Nitro-oleic acid inhibits vascular endothelial inflammatory responses and the endothelial-mesenchymal transition.
Ambrozova G; Fidlerova T; Verescakova H; Koudelka A; Rudolph TK; Woodcock SR; Freeman BA; Kubala L; Pekarova M
Biochim Biophys Acta; 2016 Nov; 1860(11 Pt A):2428-2437. PubMed ID: 27431604
[TBL] [Abstract][Full Text] [Related]
22. Nitro-oleic acid protects the mouse kidney from ischemia and reperfusion injury.
Liu H; Jia Z; Soodvilai S; Guan G; Wang MH; Dong Z; Symons JD; Yang T
Am J Physiol Renal Physiol; 2008 Oct; 295(4):F942-9. PubMed ID: 18753300
[TBL] [Abstract][Full Text] [Related]
23. Nitro-fatty acids reduce atherosclerosis in apolipoprotein E-deficient mice.
Rudolph TK; Rudolph V; Edreira MM; Cole MP; Bonacci G; Schopfer FJ; Woodcock SR; Franek A; Pekarova M; Khoo NK; Hasty AH; Baldus S; Freeman BA
Arterioscler Thromb Vasc Biol; 2010 May; 30(5):938-45. PubMed ID: 20167658
[TBL] [Abstract][Full Text] [Related]
24. A slow-releasing form of prostacyclin agonist (ONO1301SR) enhances endogenous secretion of multiple cardiotherapeutic cytokines and improves cardiac function in a rapid-pacing-induced model of canine heart failure.
Shirasaka T; Miyagawa S; Fukushima S; Saito A; Shiozaki M; Kawaguchi N; Matsuura N; Nakatani S; Sakai Y; Daimon T; Okita Y; Sawa Y
J Thorac Cardiovasc Surg; 2013 Aug; 146(2):413-21. PubMed ID: 23541854
[TBL] [Abstract][Full Text] [Related]
25. Nitroalkene fatty acids modulate bile acid metabolism and lung function in obese asthma.
Manni ML; Heinrich VA; Buchan GJ; O'Brien JP; Uvalle C; Cechova V; Koudelka A; Ukani D; Rawas-Qalaji M; Oury TD; Hart R; Ellgass M; Mullett SJ; Fajt ML; Wenzel SE; Holguin F; Freeman BA; Wendell SG
Sci Rep; 2021 Sep; 11(1):17788. PubMed ID: 34493738
[TBL] [Abstract][Full Text] [Related]
26. Electrophilic nitro-fatty acids suppress allergic contact dermatitis in mice.
Mathers AR; Carey CD; Killeen ME; Diaz-Perez JA; Salvatore SR; Schopfer FJ; Freeman BA; Falo LD
Allergy; 2017 Apr; 72(4):656-664. PubMed ID: 27718238
[TBL] [Abstract][Full Text] [Related]
27. Calcineurin protects the heart in a murine model of dilated cardiomyopathy.
Heineke J; Wollert KC; Osinska H; Sargent MA; York AJ; Robbins J; Molkentin JD
J Mol Cell Cardiol; 2010 Jun; 48(6):1080-7. PubMed ID: 19854199
[TBL] [Abstract][Full Text] [Related]
28. Nitro-oleic acid (NO
Zhao C; Chen W; Gong F; Wang W; Fan C; Li Y; Lan T; Wang W; Yuan M
Transl Androl Urol; 2024 Apr; 13(4):537-547. PubMed ID: 38721285
[TBL] [Abstract][Full Text] [Related]
29. Correlation of plasma TSG-6 with cardiac function, myocardial fibrosis, and prognosis in dilated cardiomyopathy patients with heart failure.
Xu L; Zhang Y; Kuang Y; Fang H; Ma Q
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Jul; 46(7):689-696. PubMed ID: 34382584
[TBL] [Abstract][Full Text] [Related]
30. Age-dependent changes in contractile function and passive elastic properties of myocardium from mice lacking muscle LIM protein (MLP).
Unsöld B; Schotola H; Jacobshagen C; Seidler T; Sossalla S; Emons J; Klede S; Knöll R; Guan K; El-Armouche A; Linke WA; Kögler H; Hasenfuss G
Eur J Heart Fail; 2012 Apr; 14(4):430-7. PubMed ID: 22371524
[TBL] [Abstract][Full Text] [Related]
31. Nitro-fatty acids decrease type I interferons and monocyte chemoattractant protein 1 in ex vivo models of inflammatory arthritis.
Hansen AL; Rahbek LSJ; Sørensen AS; Hundahl MP; Lomholt S; Holm CK; Kragstrup TW
BMC Immunol; 2021 Dec; 22(1):77. PubMed ID: 34920714
[TBL] [Abstract][Full Text] [Related]
32. Fatty acid nitroalkene reversal of established lung fibrosis.
Koudelka A; Cechova V; Rojas M; Mitash N; Bondonese A; St Croix C; Ross MA; Freeman BA
Redox Biol; 2022 Apr; 50():102226. PubMed ID: 35150970
[TBL] [Abstract][Full Text] [Related]
33. Cardiac remodeling is not modulated by overexpression of muscle LIM protein (MLP).
Kuhn C; Frank D; Dierck F; Oehl U; Krebs J; Will R; Lehmann LH; Backs J; Katus HA; Frey N
Basic Res Cardiol; 2012 May; 107(3):262. PubMed ID: 22421737
[TBL] [Abstract][Full Text] [Related]
34. Prolonged mechanical unloading preserves myocardial contractility but impairs relaxation in rat heart of dilated cardiomyopathy accompanied by myocardial stiffness and apoptosis.
Muranaka H; Marui A; Tsukashita M; Wang J; Nakano J; Ikeda T; Sakata R
J Thorac Cardiovasc Surg; 2010 Oct; 140(4):916-22. PubMed ID: 20381089
[TBL] [Abstract][Full Text] [Related]
35. Oleanolic acid modulates the immune-inflammatory response in mice with experimental autoimmune myocarditis and protects from cardiac injury. Therapeutic implications for the human disease.
Martín R; Cordova C; San Román JA; Gutierrez B; Cachofeiro V; Nieto ML
J Mol Cell Cardiol; 2014 Jul; 72():250-62. PubMed ID: 24732212
[TBL] [Abstract][Full Text] [Related]
36. Cardiac fibrosis and dysfunction in experimental diabetic cardiomyopathy are ameliorated by alpha-lipoic acid.
Li CJ; Lv L; Li H; Yu DM
Cardiovasc Diabetol; 2012 Jun; 11():73. PubMed ID: 22713251
[TBL] [Abstract][Full Text] [Related]
37. [Effect of LY249002 on myocardial structure and cardiac function in rats with dilated cardiomyopathy].
Zhu W; Zhu F; Zhang B; Liu W; Xiao J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Jan; 43(1):35-40. PubMed ID: 30154289
[TBL] [Abstract][Full Text] [Related]
38. Nitro-oleic acid inhibits angiotensin II-induced hypertension.
Zhang J; Villacorta L; Chang L; Fan Z; Hamblin M; Zhu T; Chen CS; Cole MP; Schopfer FJ; Deng CX; Garcia-Barrio MT; Feng YH; Freeman BA; Chen YE
Circ Res; 2010 Aug; 107(4):540-8. PubMed ID: 20558825
[TBL] [Abstract][Full Text] [Related]
39. Muscle LIM protein deficiency leads to alterations in passive ventricular mechanics.
Omens JH; Usyk TP; Li Z; McCulloch AD
Am J Physiol Heart Circ Physiol; 2002 Feb; 282(2):H680-7. PubMed ID: 11788418
[TBL] [Abstract][Full Text] [Related]
40. Nitro-fatty acids: New drug candidates for chronic inflammatory and fibrotic diseases.
Schopfer FJ; Vitturi DA; Jorkasky DK; Freeman BA
Nitric Oxide; 2018 Sep; 79():31-37. PubMed ID: 29944935
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
